Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

Agenus Inc. CEO Garo H. Armen received 1,040 shares of common stock in lieu of cash salary for the pay period ending May 31, 2024, as part of an approved compensation arrangement.

Summary

• Garo H. Armen, CEO of Agenus Inc., received 1,040 shares of Agenus Inc. common stock on May 31, 2024, in lieu of cash salary.
• This arrangement was approved by the Agenus Inc. Compensation Committee.
• The shares were issued according to the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested upon issuance.
• The price of the stock was $10.86, which was the closing price of Agenus Inc. common stock on May 31, 2024.
• Following the transaction, Dr. Armen directly owns 73,587 shares.
• Dr. Armen also indirectly owns 31,298 shares through IRA accounts and 28,950 shares as trustee and general partner.
• Dr. Armen disclaims beneficial ownership to the extent of his pecuniary interest in shares held by Pixie Partners.

Sentiment

Score: 7

Explanation: Neutral to slightly positive. The CEO taking stock in lieu of cash aligns interests with shareholders, but it's a routine transaction.

Positives

• The CEO accepting stock in lieu of cash salary could be viewed positively as it aligns his interests with those of the shareholders.
• The shares are fully vested upon issuance, providing immediate ownership and incentive.

Industry Context

This type of compensation arrangement, where executives receive stock in lieu of cash, is not uncommon in the biotech industry, especially for companies focused on long-term growth.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the biotechnology sector.
• Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize stock options and restricted stock units as part of their executive compensation packages.
• The specific amount and vesting schedules vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the CEO accepting stock in lieu of cash as a positive sign of alignment with their interests.
• Employees may see this as a commitment from the CEO to the company's long-term success.

Key Dates